US Stock MarketDetailed Quotes

ELYM Eliem Therapeutics

Watchlist
  • 5.160
  • +0.070+1.38%
Close Oct 1 16:00 ET
  • 5.230
  • +0.070+1.36%
Post 19:59 ET
346.03MMarket Cap-2324P/E (TTM)

Eliem Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
739.62%56.37M
-87.18%3.01M
-10.77%40.28M
-46.39%5.12M
-42.83%5M
-51.00%6.71M
78.48%23.44M
26.53%45.14M
-10.74%9.55M
-6.77%8.75M
Selling and administrative expenses
21.18%3.67M
-89.20%1.91M
31.41%24.86M
-56.88%2M
-52.67%2.13M
-38.65%3.03M
263.67%17.72M
53.21%18.92M
21.00%4.63M
32.29%4.49M
-General and administrative expense
21.18%3.67M
-89.20%1.91M
31.41%24.86M
-56.88%2M
-52.67%2.13M
-38.65%3.03M
263.67%17.72M
53.21%18.92M
21.00%4.63M
32.29%4.49M
Research and development costs
1,329.09%52.71M
-80.93%1.09M
-41.21%15.41M
-36.53%3.13M
-32.46%2.88M
-57.94%3.69M
-30.75%5.72M
12.40%26.21M
-28.38%4.93M
-28.90%4.26M
Operating profit
-739.62%-56.37M
87.18%-3.01M
10.77%-40.28M
46.39%-5.12M
42.83%-5M
51.00%-6.71M
-78.48%-23.44M
-26.53%-45.14M
10.74%-9.55M
6.77%-8.75M
Net non-operating interest income expense
49.00%1.34M
236.00%4.62M
77.50%1.35M
229.24%1.26M
900K
1.38M
760K
383K
Non-operating interest income
----
49.00%1.34M
236.00%4.62M
77.50%1.35M
229.24%1.26M
----
--900K
--1.38M
--760K
--383K
Other net income (expense)
-0.74%1.48M
-113.31%-33K
136.12%536K
-87.21%132K
82.69%-228K
266.93%1.49M
444.44%248K
87.43%-1.48M
553.16%1.03M
-467.67%-1.32M
Gain on sale of security
-100.52%-2K
-113.31%-33K
136.12%536K
-87.21%132K
82.69%-228K
136.85%384K
257.96%248K
-772.94%-1.48M
953.06%1.03M
-422.62%-1.32M
Other non- operating income (expenses)
33.78%1.49M
----
----
----
----
655.10%1.11M
----
----
----
----
Income before tax
-951.51%-54.89M
92.39%-1.7M
22.38%-35.12M
53.09%-3.64M
59.02%-3.97M
64.24%-5.22M
-68.81%-22.29M
4.71%-45.24M
26.39%-7.76M
-0.70%-9.68M
Income tax
Net income
-951.51%-54.89M
92.39%-1.7M
22.38%-35.12M
53.09%-3.64M
59.02%-3.97M
64.24%-5.22M
-68.81%-22.29M
4.71%-45.24M
26.39%-7.76M
-0.70%-9.68M
Net income continuous Operations
-951.51%-54.89M
92.39%-1.7M
22.38%-35.12M
53.09%-3.64M
59.02%-3.97M
64.24%-5.22M
-68.81%-22.29M
4.71%-45.24M
26.39%-7.76M
-0.70%-9.68M
Minority interest income
Net income attributable to the parent company
-951.51%-54.89M
92.39%-1.7M
22.38%-35.12M
53.09%-3.64M
59.02%-3.97M
64.24%-5.22M
-68.81%-22.29M
4.71%-45.24M
26.39%-7.76M
-0.70%-9.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-951.51%-54.89M
92.39%-1.7M
22.38%-35.12M
53.09%-3.64M
59.02%-3.97M
64.24%-5.22M
-68.81%-22.29M
13.04%-45.24M
26.39%-7.76M
11.47%-9.68M
Basic earnings per share
-852.63%-1.81
92.86%-0.06
24.42%-1.3
55.17%-0.13
59.46%-0.15
66.07%-0.19
-68.00%-0.84
59.43%-1.72
27.50%-0.29
47.14%-0.37
Diluted earnings per share
-852.63%-1.81
92.86%-0.06
24.42%-1.3
55.17%-0.13
59.46%-0.15
66.07%-0.19
-68.00%-0.84
59.43%-1.72
27.50%-0.29
47.14%-0.37
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 739.62%56.37M-87.18%3.01M-10.77%40.28M-46.39%5.12M-42.83%5M-51.00%6.71M78.48%23.44M26.53%45.14M-10.74%9.55M-6.77%8.75M
Selling and administrative expenses 21.18%3.67M-89.20%1.91M31.41%24.86M-56.88%2M-52.67%2.13M-38.65%3.03M263.67%17.72M53.21%18.92M21.00%4.63M32.29%4.49M
-General and administrative expense 21.18%3.67M-89.20%1.91M31.41%24.86M-56.88%2M-52.67%2.13M-38.65%3.03M263.67%17.72M53.21%18.92M21.00%4.63M32.29%4.49M
Research and development costs 1,329.09%52.71M-80.93%1.09M-41.21%15.41M-36.53%3.13M-32.46%2.88M-57.94%3.69M-30.75%5.72M12.40%26.21M-28.38%4.93M-28.90%4.26M
Operating profit -739.62%-56.37M87.18%-3.01M10.77%-40.28M46.39%-5.12M42.83%-5M51.00%-6.71M-78.48%-23.44M-26.53%-45.14M10.74%-9.55M6.77%-8.75M
Net non-operating interest income expense 49.00%1.34M236.00%4.62M77.50%1.35M229.24%1.26M900K1.38M760K383K
Non-operating interest income ----49.00%1.34M236.00%4.62M77.50%1.35M229.24%1.26M------900K--1.38M--760K--383K
Other net income (expense) -0.74%1.48M-113.31%-33K136.12%536K-87.21%132K82.69%-228K266.93%1.49M444.44%248K87.43%-1.48M553.16%1.03M-467.67%-1.32M
Gain on sale of security -100.52%-2K-113.31%-33K136.12%536K-87.21%132K82.69%-228K136.85%384K257.96%248K-772.94%-1.48M953.06%1.03M-422.62%-1.32M
Other non- operating income (expenses) 33.78%1.49M----------------655.10%1.11M----------------
Income before tax -951.51%-54.89M92.39%-1.7M22.38%-35.12M53.09%-3.64M59.02%-3.97M64.24%-5.22M-68.81%-22.29M4.71%-45.24M26.39%-7.76M-0.70%-9.68M
Income tax
Net income -951.51%-54.89M92.39%-1.7M22.38%-35.12M53.09%-3.64M59.02%-3.97M64.24%-5.22M-68.81%-22.29M4.71%-45.24M26.39%-7.76M-0.70%-9.68M
Net income continuous Operations -951.51%-54.89M92.39%-1.7M22.38%-35.12M53.09%-3.64M59.02%-3.97M64.24%-5.22M-68.81%-22.29M4.71%-45.24M26.39%-7.76M-0.70%-9.68M
Minority interest income
Net income attributable to the parent company -951.51%-54.89M92.39%-1.7M22.38%-35.12M53.09%-3.64M59.02%-3.97M64.24%-5.22M-68.81%-22.29M4.71%-45.24M26.39%-7.76M-0.70%-9.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -951.51%-54.89M92.39%-1.7M22.38%-35.12M53.09%-3.64M59.02%-3.97M64.24%-5.22M-68.81%-22.29M13.04%-45.24M26.39%-7.76M11.47%-9.68M
Basic earnings per share -852.63%-1.8192.86%-0.0624.42%-1.355.17%-0.1359.46%-0.1566.07%-0.19-68.00%-0.8459.43%-1.7227.50%-0.2947.14%-0.37
Diluted earnings per share -852.63%-1.8192.86%-0.0624.42%-1.355.17%-0.1359.46%-0.1566.07%-0.19-68.00%-0.8459.43%-1.7227.50%-0.2947.14%-0.37
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data